Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

anacetrapib

A cholesteryl ester transfer protein (CETP) inhibitor with hypocholesterolemic properties. Anacetrapib reduces the transfer of cholesteryl ester from… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin… Expand
  • table 1
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Present guidelines emphasise the importance of low concentrations of LDL cholesterol (LDL-C) in patients with familial… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
We investigated the effects of the cholesteryl ester (CE) transfer protein inhibitor anacetrapib (ANA) on plasma lipids… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Anacetrapib is a cholesteryl ester transfer protein inhibitor that raises high-density lipoprotein (HDL) cholesterol… Expand
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Objective—To examine the effects of treatments with niacin or anacetrapib (an inhibitor of cholesteryl ester transfer protein) on… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Systematic identification of protein-drug interaction networks is crucial to correlate complex modes of drug action to clinical… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND High-density lipoprotein cholesterol (HDL-C) levels are inversely associated with cardiovascular risk. Cholesteryl… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Residual cardiovascular (CV) risk often remains high despite statin therapy to lower low-density lipoprotein… Expand
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Inhibition of cholesteryl ester transfer protein (CETP) with torcetrapib in humans increases plasma high density lipoprotein (HDL… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND The inhibition of cholesteryl ester transfer protein (CETP) is considered a potential new mechanism for treatment of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
Is this relevant?